TraceLink Leads Pharmaceutical Integrity Panel at World Summit on Innovation and Entrepreneurship, Named Global Hot 100 Enterprise

Share Article

TraceLink's President and CEO Shabbir Dahod will lead an interactive panel of healthcare, life science and supply chain experts in discussing solutions to improve global pharmaceutical integrity and access to safe medicines at the World Summit on Innovation and Entrepreneurship, Sept. 28th in Boston MA.

World Summit on Innovation and Entrepreneurship

TraceLink Inc., helping businesses securely supply every global market opportunity on-time and in-full with the TraceLink Business Cloud, announced today that Shabbir Dahod, TraceLink’s President and CEO, will be leading a panel discussion on global pharmaceutical integrity and access to safe medicines at the World Summit on Innovation and Entrepreneurship taking place Sept 26-28th at the Seaport World Trade Center in Boston, MA. TraceLink also announced that the company has been named a Global Hot 100 Enterprise by the World Summit, recognizing the company for its passion in developing innovative technologies and fostering business collaboration to address growing concerns in protecting patient safety and ensuring efficient global production and supply of medicines.

The World Summit brings together leading global entrepreneurs, innovators, executives and policy makers to discuss challenges and create solutions for key issues in healthcare, energy, education and communications through the intersection of innovative business models with emerging technologies such as social media, collaborative environments and cloud computing.

Mr. Dahod will lead an interactive session entitled “Stop Dangerous Drugs: Protecting Integrity, Serving Patients in a Global Pharmaceutical Marketplace” at 11:20am on Friday, Sept. 28th. With almost 2 billion people globally lacking regular access to essential medicines and over 1,700 incidents of drug counterfeiting reported worldwide in 2011, ensuring safe and efficient supply of needed medicines to global patients is a critical issue. The panel will examine the human cost and business impacts due to drug counterfeits, substandard medicines and distribution barriers across the globe. The panel will then discuss how new industry, government and NGO partnership models can be used in conjunction with emerging technologies to create a more efficient global supply network.

Joining Mr. Dahod in examining this topic are four noted healthcare, life science and supply chain leaders:

  •     Roger Bate, Fellow at the American Enterprise Institute and author of the recent book “Phake: The Deadly World of Falsified and Substandard Medicines”
  •     Prashant Yadav, Director of the Health Care Research Initiative at the William Davidson Institute, University of Michigan
  •     Peggy Staver, Director of Product Integrity at Pfizer Inc.
  •     Roddy Martin, Senior VP of Global Supply Chain and Supply Chain Transformation Thought Leader at CCI

At the World Summit, TraceLink will also be honored as one of the Global Hot 100 Enterprises, those companies leading technical innovation and business thought leadership to solve growing global challenges. TraceLink was recognized for its innovative TraceLink Business Cloud, a collaborative supply network platform that connects people, processes and information across functions and supply chain relationships, resulting in increased agility, improved performance and reduced risk in supply, manufacturing and distribution. TraceLink was also recognized for its leadership in bringing together business and technology leaders to discuss cross-company collaborative solutions for improving supply performance and ensuring regulatory compliance through venues such as its yearly Supply Network NEXUS life science leadership event.

To learn more about TraceLink’s solutions for increasing supply network collaboration, reducing risk through external pharmaceutical quality management and oversight, improving supply planning with agile S&OP collaboration and protecting drug products from counterfeiting and theft threats such as those that recently impacted Genentech’s Avastin and Eli Lilly’s Prozac, visit http://www.tracelink.com.

About TraceLink
TraceLink helps companies securely supply every global market opportunity on-time and in-full through the TraceLink Business Cloud. The TraceLink Business Cloud is an Amazon cloud-based application platform that connects business transactions, partner networks and professional relationships across companies and functions. The result is improved visibility, predictability and performance across global supply, manufacturing and distribution operations. The TraceLink Business Cloud combines an “integrate-once, interoperate-with-everyone” transaction translation platform, user-managed business collaboration workspaces and cross-linked business process modules on a globally elastic cloud infrastructure to help companies realize their strategic goals in improving global supply network performance.

TraceLink is funded by FirstMark Capital, a venture capital firm managing more than $2 billion in capital commitments. For more information on TraceLink and our solutions, visit http://www.tracelink.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brian Daleiden
Follow us on
Visit website